Are the new 2023 ACR/EULAR classification criteria suitable for advancing the knowledge of obstetric antiphospholipid syndrome?

Affiliations

¹ Division of Reumatology, Spain; Department of Medicine and Psychiatry, Universidad de Cantabria, Spain. Electronic address: vmartinezt64@gmail.com.
² Division of Reumatology, Spain.
³ Division of Obstetrics and Gynecology, Spain.
⁴ Immunology Department, Spain; Department of Molecular Biology, University of Cantabria, Spain.
⁵ Immunology Department, Spain.
⁶ Division of Internal Medicine, Hospital Marqués de Valdecilla-IDIVAL, Santander, Spain; Department of Medicine and Psychiatry, Universidad de Cantabria, Spain.

Víctor M Martínez-Taboada et al. Autoimmun Rev. 2024 Jul-Aug.

. 2024 Jul-Aug;23(7-8):103592.

doi: 10.1016/j.autrev.2024.103592. Epub 2024 Aug 9.

¹ Division of Reumatology, Spain; Department of Medicine and Psychiatry, Universidad de Cantabria, Spain. Electronic address: vmartinezt64@gmail.com.
² Division of Reumatology, Spain.
³ Division of Obstetrics and Gynecology, Spain.
⁴ Immunology Department, Spain; Department of Molecular Biology, University of Cantabria, Spain.
⁵ Immunology Department, Spain.
⁶ Division of Internal Medicine, Hospital Marqués de Valdecilla-IDIVAL, Santander, Spain; Department of Medicine and Psychiatry, Universidad de Cantabria, Spain.

No abstract available

Keywords: Antiphospholipid antibodies, classification criteria, non-criteria obstetric manifestations; Antiphospholipid syndrome; Pregnancy.

Conflict of interest statement

Declaration of competing interest There is no conflict of interest from any author concerning this paper.